VanEck Biotech ETF
BBHNASDAQVanEckEquity
As of Oct 23, 2026 close
- Assets (AUM)
- $489.80M
- Expense ratio
- 0.35%
- Dividend yield
- 0.39%
- Holdings
- 25
- 52-week range
- $176.30$248.78
- Volume (live)
- -
- Avg. volume (3M)
- 10.94K
BBH ETF: VanEck Biotech ETF - Price, Holdings & Analysis
VanEck Biotech ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $246.05 - $247.69 |
|---|---|
| 52-Week High | $248.78 |
| 52-Week Low | $176.30 |
| Open | $247.53 |
| Volume (last close) | 4.93K |
| Average Volume (3M) | 10.94K |
| 1 Day Change | −0.82% |
|---|---|
| 1 Month Change | +3.41% |
| 6 Month Change | +32.17% |
| YTD Change | +30.58% |
| 1 Year Change | +40.03% |
| 5 Year Change | +26.63% |
| 10 Year Change | +132.50% |
| Annual Dividend | $0.96 |
|---|---|
| Dividend Yield | 0.39% |
| Last Dividend Ex-Date | Dec 22, 2025 |
| Dividend Growth YoY | −23.58% |
| Assets (AUM) | $489.80M |
|---|---|
| Expense Ratio | 0.35% |
| Total Holdings | 25 |
| Inception Date | Dec 19, 2011 |
| 50-Day MA | $236.92 |
|---|---|
| 200-Day MA | $204.37 |
| RSI | 60.68 |
| Stochastic %K | 100.00 |
| Stochastic %D | 74.87 |
Source: Exchange price data and fund disclosures. Data as of Oct 23, 2026. Data sources and methodology
BBH at a Glance
VanEck Biotech ETF (BBH) is an equity ETF from VanEck, launched in December 2011. It manages $489.80M in assets and charges a 0.35% expense ratio, about $35 a year per $10,000 invested.
As of its Oct 4, 2026 holdings, it holds 25 positions. The largest are Amgen Inc (AMGN, 15.58%), Gilead Sciences, Inc. (GILD, 13.32%) and Vertex Pharmaceuticals Incorporated (VRTX, 8.59%). The top 10 holdings make up 74.6% of the fund. By sector it leans toward Healthcare (100.0%). 100.0% of assets are in the United States.
It pays distributions yielding 0.39% at the Oct 23, 2026 close, $0.96 per share over the trailing 12 months. As of the Oct 23, 2026 close, the share price is up 40.0% over one year, up 26.6% over five years and up 132.5% over ten years (price change, excluding distributions).
Frequently Asked Questions About VanEck Biotech ETF
What is the current price of BBH?
The latest BBH price is $246.57 (Oct 23, 2026 close). The 52-week range is $176.30–$248.78. The share price is up 40.0% over the past year (price change, excluding distributions).
What is the expense ratio for BBH?
BBH's annual expense ratio is 0.35%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does BBH pay dividends?
Yes, BBH pays a 0.39% dividend yield (trailing 12 months, at the Oct 23, 2026 close). The most recent ex-dividend date was December 22, 2025. View full dividend history in the Dividends section.
What are the top holdings of BBH?
As of Oct 4, 2026, BBH's largest holdings are Amgen Inc (15.6%), Gilead Sciences, Inc. (13.3%), Vertex Pharmaceuticals Incorporated (8.6%) (combined weight: 37.5%). The fund holds 25 total positions. View the complete portfolio breakdown in the Holdings section.
How does BBH compare to similar ETFs?
Compare BBH (0.35% expense ratio, $490M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.